IDEAYA BIOSCIENCES, INC. : Other Events (form 8-K) : vimarsa

Item 8.01 Other Events


Clinical Updates


On April 23, 2023, IDEAYA Biosciences, Inc. announced interim
results from its Phase 2 clinical trial evaluating darovasertib and crizotinib
synthetic... | June 18, 2023

Related Keywords

Sydney , New South Wales , Australia , United States , Russia , Ukraine , , While The Company , Biosciences Inc , Company Annual Report On Form , Company Phase , Vincent Hospital Sydney , Exchange Commission , Clinical Updates , Data Update , Crizotinib Combination , Overall Response Rate , Disease Control Rate , Typec Meeting Supports Initiation , Potential Registrational , Adjuvant Primary , Hospital Sydney Limited , Patient Population , Private Securities Litigation Reform Act , Annual Report , Edgar Online ,